Novel and Emerging Drugs for Rarer Chronic Lymphoid Leukaemias

E-ISSN： 1873-5576|12|5|484-504

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.5, 2012-05, pp. : 484-504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for rarer chronic lymphoid leukemias

By Robak Tadeusz

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 95-118

Informa Healthcare

Access to resources Recommend Favorite

Purine Nucleoside Analogs in the Treatment of Rarer Chronic Lymphoid Leukemias

Current Pharmaceutical Design, Vol. 18, Iss. 23, 2012-08 ,pp. : 3373-3388

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Drugs for Chronic Lymphoid Leukemias: Mechanism of Action and Therapeutic Activity

Current Medicinal Chemistry, Vol. 16, Iss. 18, 2009-06 ,pp. : 2212-2234

Bentham Science Publishers

Access to resources Recommend Favorite

Novel and Emerging Drugs for Chronic Lymphocytic Leukemia

Current Cancer Drug Targets, Vol. 12, Iss. 5, 2012-05 ,pp. : 471-483

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for chronic constipation

By Crowell Michael D Harris Lucinda A Lunsford Tisha N DiBaise John K

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 3, 2009-09 ,pp. : 493-504

Informa Healthcare

Access to resources Recommend Favorite